NCT03006848 2026-02-23
A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma
St. Jude Children's Research Hospital
Phase 2 Completed
St. Jude Children's Research Hospital
Maria Sklodowska-Curie National Research Institute of Oncology
Memorial Sloan Kettering Cancer Center